MedTrace Logo

To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee

NCT02049606 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2017-09-20

No results posted yet for this study

Summary

This is a randomized, double-blind study to compare the efficacy and safety of LAYLA tablet and CENATONE tablet in the treatment of osteoarthritis of the knee.

Conditions

  • Osteoarthritis of the Knee

Interventions

DRUG

LAYLA tablet

1 Tablet twice a day

DRUG

CENATONE tablet

2 Tablets once a day

Sponsors & Collaborators

  • PMG Pharm Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Seung Baik Kang, MD · SMG-SNU Boramae Medical Center

  • Jeong Ku Ha, MD · Inje University

  • Han Jun Lee, MD · Chung-Ang University Hosptial, Chung-Ang University College of Medicine

  • Yong In, MD · The Catholic University of Korea

  • Jong Min Kim, MD · Asan Medical Center

  • Sahng Hoon Lee, MD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-24
Primary Completion
2015-05-11
Completion
2016-05-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02049606 on ClinicalTrials.gov